Stay updated on Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.

Latest updates to the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page
- CheckyesterdayChange DetectedFooter update: Revision: v3.3.3 has been added. The previous Revision: v3.3.2 text and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedThe notice about government funding and operation status at the bottom of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedNo significant content or layout changes were observed on the Study Details page; essential trial information remains the same.SummaryDifference0.5%

- Check79 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference4%

- Check87 days agoChange DetectedThe page updated from v3.0.2 to v3.1.0 and adds a phone-like contact number +3227645106; no other substantive content changes. If no other updates are present, then this is a minor version bump with an added contact reference.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.